SELLAS to present preclinical SLS009 data at 2026 AACR pancreatic conference
SELLAS Life Sciences will present preclinical data on SLS009 (tambiciclib) at the 2026 AACR Conference on Pancreatic Cancer.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
SELLAS Life Sciences will present preclinical data on SLS009 (tambiciclib) at the 2026 AACR Conference on Pancreatic Cancer.
SELLAS Life Sciences plans to present preclinical data on SLS009 in pancreatic ductal adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer.